$71.24
4.26% today
Nasdaq, Nov 04, 08:40 pm CET
ISIN
US74006W1080
Symbol
PRAX
Sector
Industry

Praxis Precision Medicines Inc Target price 2024 - Analyst rating & recommendation

Praxis Precision Medicines Inc Classifications & Recommendation:

Buy
90%
Hold
10%

Praxis Precision Medicines Inc Price Target

Target Price $148.67
Price $68.33
Potential
Number of Estimates 9
9 Analysts have issued a price target Praxis Precision Medicines Inc 2025 . The average Praxis Precision Medicines Inc target price is $148.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 9 Analysts recommend Praxis Precision Medicines Inc to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Praxis Precision Medicines Inc stock has an average upside potential 2025 of . Most analysts recommend the Praxis Precision Medicines Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 2.45 1.48
39.68%
EBITDA Margin -5,140.41% -11,330.42%
120.42%
Net Margin -13,548.34% -10,076.98%
25.62%

10 Analysts have issued a sales forecast Praxis Precision Medicines Inc 2024 . The average Praxis Precision Medicines Inc sales estimate is

$1.5m
Unlock
. This is
16.51% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.4m 35.59%
Unlock
, the lowest is
$800k 54.80%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.5m
2024
$1.5m 39.68%
Unlock
2025
$969k 34.41%
Unlock
2026
$45.1m 4,553.19%
Unlock
2027
$127m 181.10%
Unlock
2028
$306m 141.42%
Unlock

1 Analyst has issued an EBITDA forecast Praxis Precision Medicines Inc 2024 . The average Praxis Precision Medicines Inc EBITDA estimate is

$-167m
Unlock
. This is
26.80% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-167m 26.80%
Unlock
, the lowest is
$-167m 26.80%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-126m 41.10%
2024
$-167m 32.95%
Unlock
2025
$-188m 12.57%
Unlock
2026
$-219m 16.44%
Unlock
2027
$-182m 17.00%
Unlock
2028
$-88.4m 51.47%
Unlock

EBITDA Margin

2023 -5,140.41%
2024
-11,330.42% 120.42%
Unlock
2025
-19,445.89% 71.63%
Unlock
2026
-486.63% 97.50%
Unlock
2027
-143.68% 70.47%
Unlock
2028
-28.88% 79.90%
Unlock

4 Praxis Precision Medicines Inc Analysts have issued a net profit forecast 2024. The average Praxis Precision Medicines Inc net profit estimate is

$-149m
Unlock
. This is
18.35% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-137m 24.64%
Unlock
, the lowest is
$-155m 15.29%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-332m 73.17%
2024
$-149m 55.14%
Unlock
2025
$-135m 9.15%
Unlock
2026
$-95.2m 29.64%
Unlock
2027
$-99.2m 4.20%
Unlock
2028
$-70.3m 29.10%
Unlock

Net Margin

2023 -13,548.34%
2024
-10,076.98% 25.62%
Unlock
2025
-13,957.16% 38.51%
Unlock
2026
-211.06% 98.49%
Unlock
2027
-78.23% 62.93%
Unlock
2028
-22.98% 70.63%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -18.69 -8.39
73.17% 55.11%
P/E negative
EV/Sales 584.25

4 Analysts have issued a Praxis Precision Medicines Inc forecast for earnings per share. The average Praxis Precision Medicines Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-8.39
Unlock
. This is
18.31% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-7.74 24.63%
Unlock
, the lowest is
$-8.70 15.29%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-18.69 73.17%
2024
$-8.39 55.11%
Unlock
2025
$-7.62 9.18%
Unlock
2026
$-5.36 29.66%
Unlock
2027
$-5.59 4.29%
Unlock
2028
$-3.96 29.16%
Unlock

P/E ratio

Current -6.65 1,915.15%
2024
-8.15 22.56%
Unlock
2025
-8.97 10.06%
Unlock
2026
-12.75 42.14%
Unlock
2027
-12.23 4.08%
Unlock
2028
-17.26 41.13%
Unlock

Based on analysts' sales estimates for 2024, the Praxis Precision Medicines Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

584.25
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
821.04
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 487.80 9,714.89%
2024
584.25 19.77%
Unlock
2025
890.76 52.46%
Unlock
2026
19.14 97.85%
Unlock
2027
6.81 64.43%
Unlock
2028
2.82 58.58%
Unlock

P/S ratio

Current 685.50 678.56%
2024
821.04 19.77%
Unlock
2025
1,251.77 52.46%
Unlock
2026
26.90 97.85%
Unlock
2027
9.57 64.43%
Unlock
2028
3.96 58.58%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today